Monday 11 February, 2008

Mylan Levothyroxine Sodium To Be Removed From Fla Negative Drug Formulary

Mylan said a Florida administrative law judge ordered that the company's Levothyroxine Sodium product be removed from the state's negative drug formulary.When a drug is included on Florida's negative formulary, pharmacists can't substitute a generic version for a prescribed brand version. Last August, Mylan filed a petition challenging the validity of Levothyroxine's inclusion on the list. Abbott Lab, which makes a brand version of Levothyroxine Sodium, intervened. In a Jan. 28 order, Mylan's subsequent motion for summary final order was granted.
The Pittsburgh generic-drug maker said Friday it will make its products available to pharmacies in Florida as soon as motions and procedural steps are satisfied.

web page statistics
Disclaimer: "IP Pharma Doc" blog is published for information purpose only. "IP Pharma Doc" blog contains no legal advice. I assume no legal responsibility for the views/information expressed here. “IP Pharma Doc” blog is my personal website and not edited by my employer, accordingly, no part of my blog should be attributed to my employer. All information on the present blog should be double checked for its accuracy and applicability. © Dr. Sarwal (2007)
 
eXTReMe Tracker